H
Hilo
Clinically certified cuffless 24/7 blood pressure monitoring
About Hilo
Hilo, formerly known as Aktiia, is a Swiss health technology company specialising in cuffless, continuous blood pressure monitoring. Its Hilo Core system combines the Hilo Band wearable, the Hilo App, and an FDA-cleared connected cuff to deliver around 30 to 35 readings per day, including overnight measurements, so users and clinicians can see patterns rather than isolated snapshots. The Hilo Band is a CE-marked Class IIa medical device, and the underlying optical blood pressure monitoring technology has been validated in multiple clinical studies and is used by more than 200,000 people worldwide. Founded in 2018 in Neuchâtel as Aktiia and rebranded to Hilo, the company closed a USD 42 million Series B in May 2025 and a USD 19 million Series B extension in July 2026 led by Dell Family Office (DFO Management), bringing total funding above USD 119 million to fuel U.S. expansion. Hilo Core launched nationwide in the United States on 21 July 2026 via hilo.com and Amazon. Keywords: blood pressure monitoring, cuffless, wearable, medical device, digital health, FDA cleared, CE-marked, continuous monitoring, hypertension, Hilo Band, Aktiia, Neuchâtel.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Neuchâtel, Switzerland
- Employees
- 64
- Open positions
- None listed
- Dealroom signal
- 71.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Consumer Electronics, Biotechnology
- Technology
- Artificial Intelligence, Hardware, Computer Vision, Connected Device, Recognition Technology, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | May 2025 | $42M | $168M | TransLink Capital · K Fund · naturalX Health Ventures · Earlybird Venture Capital | ↗ |
| EARLY VCOther financing | Feb 2024 | $30M | $120M | Verve Ventures · Khosla Ventures · 415 Capital · Redalpine | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Hilo is 21K monthly website visits, down 44.7% over the last three months. Hilo's team declined 12.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
TransLink Capital
Mladen Barbaric
Redalpine
Christian Wenger- CJChad Jackson
Series A13 investors entered at this stage
Verve Ventures
Lukka
Credit Suisse Entrepreneur Capital- BHBarbaric Holdings
- SCSparks Street Capital
Molten Ventures
VERVE CAPITAL
415 Capital
Khosla Ventures
Earlybird Venture Capital
Wellington Partners
K Fund
naturalX Health Ventures
Other known investors2 additional known investors
CMES
Swissnex
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hilo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hilo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.